Raises $5 million in Placement
Filed with ASX ·
6ix hasn’t read this filing yet.
Arovella Therapeutics Limited on 6ix
Earlier from Arovella Therapeutics
- Signs International Purchase Agreement
- Secures Patents for Major World Markets
- Market Update on Financial Results
- Half Yearly Report & Accounts
- Expands patent coverage on PAP Technology
Later from Arovella Therapeutics
- Bergen Funding
- SUDA granted Canadian Patent for SUD-002
- Business development update
- Update on HC Berlin Pharma
- Technology patent application
Follow Arovella Therapeutics into a list and get an email when it puts out news.
Follow Arovella Therapeutics